Australia TGA ARTG recordClinical chemistry-specific protein IVDs
Australia TGA ARTG Registered Device · Abacus dx Pty Ltd · Sero AS · Class IIa · Started July 14, 2017
Good Name: Abacus dx Pty Ltd - Clinical chemistry-specific protein IVDs
- Risk Class
- Class IIa
- Product Type
- IVD
- ARTG Category
- IVD
- Start Date
- July 14, 2017
- Effective Date
- July 14, 2017
- Name
- Sero AS
- Country
- Norway
- Address
- Stasjonsveien 44, Billingstad, N-1375
IVDs intended to be used as quality control material to monitor laboratory measurement procedures of clinical chemistry specific proteins.
Access comprehensive regulatory information for Clinical chemistry-specific protein IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Abacus dx Pty Ltd, manufactured by Sero AS in Norway. The device registration started on July 14, 2017.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.